Total : 165 View more »
Consultants from Moorfields Eye Hospital Dubai will present a series of professional development sessions, in partnership with Johnson & Johnson Vision Care, a division of Johnson & Johnson (Middle...
A U.S. District judge has upheld a verdict against Abbott Labs that could require the drug maker to pay nearly $1.7 billion to Johnson & Johnson, according to published reports.
U.S. health care products maker bought 18 percent stake in biotechnology company Crucell for $440 million in hopes of developing a universal flu vaccine.
http://www.manufacturing.net/News-Johnson-Johnson-Buys-Crucell-Stake-092809.aspx
Johnson Johnson on November 3 announced global restructuring initiatives designed to strengthen the company’s position as the world’s leading global health care company.
Total : 88 View more »
Nov 03, 2009 (SmarTrend(R) News Watch via COMTEX) --
11/3/2009 - Johnson & Johnson (NYSE:JNJ) said Tuesday that it will trim management, cut jobs, and set other restructuring moves in order to save the company up to $900 million next year. The job cuts will affect about 6% to 7% of its global work force of roughly 118,700 workers, prompting a restructuring charge of up to $1.3 billion pretax in Q4. The company reaffirmed EPS guidance of $4.54 and $4.59 for 2009, vs. the consensus estimates of $4.58. Chairman and CEO William C. Weldon said in a statement, "Johnson & Johnson has long adhered to a broad-based operating model and set of sound management principles that have driven our success." He added, "These types of changes are difficult under any circumstances, and will have a very personal impact on people who have been dedicated to the mission of Johnson & Johnson. We recognize their contributions to the achievements of our business, and are committed to treating them fairly and with respect throughout this process."
Write to Chip Brian at cbrian@tradethetrend.com
---------------------------------------------------------------------------------------------
SmarTrend analyzes over 5,000 securities simultaneously throughout the trading day and provides its subscribers with trend change alerts in real time. To get a free trial of our trading calls and maximize your trading results, please visit http://www.TradeTheTrend.com.
Get exclusive, actionable insight into how the market is expected to trend prior to market open with our free morning newsletter. Sign up at: http://www.TradeTheTrend.com/signup.html
Tags: business ceo contributions eps market nyse restructuring securities
Companies: Johnson & Johnson (JNJ)
Nov 03, 2009 (EarningsWhispers Guidance Summaries via Comtex) --
Johnson & Johnson (NYSE: JNJ) said it continues to expect 2009 earnings of $4.54 to $4.59 per share. The current consensus earnings estimate is $4.58 per share for the year ending December 31, 2009.
This earnings guidance summary was provided by EarningsWhispers, a leading provider of earnings expectations - including corporate guidance announcements and analysts' expectations that differ from published estimates. http://www.earningswhispers.com
Companies: Johnson & Johnson (JNJ)
DUBLIN, Nov 06, 2009 (BUSINESS WIRE) --
Research and Markets (http://www.researchandmarkets.com/research/d67d72/johnson_johnson) has announced the addition of the "Johnson & Johnson: Corporate Analysis" company profile to their offering.
This company profile is a premium company information product offering an unmatched depth and breadth of content. It analyzes the strategic positioning of the company - how the company has evolved and how it has been performing over the years.
Sectional Highlights:
Structure of the organization, partnerships, mergers & acquisitions and recent developments have been examined Business segments of the company have been explored along with analysis of key products and services SWOT Analysis highlights the weaknesses of the company and the threats to which it is exposed; the strengths of the company and the way the company has positioned itself to take advantage of the opportunities Business and marketing strategies boosting earnings, brand value and competitive edge have been discussed Key financial indicators have been analyzed Competitive positioning of the company has been evaluated in terms of sales, profitability and stock performance, as compared to its competitors
Key Benefits:
Provides input for strategic business planning Targets business opportunities & risks Exploits competitive intelligence
Target Audience:
Investment Managers Venture Capitalists Management Consultants Research Companies Other Industry Professionals
Key Topics Covered:
Company Backgrounder
Corporate Overview Key Facts Corporate Timeline
Business Focus
Major Segments Products & Services
Corporate Overview
Organizational Structure Executive Biographies Ownership Structure Subsidiaries Key Partnerships Mergers & Acquisitions Significant Developments
Strategic Analysis
SWOT Strategic Focus
Financial Analysis
Financial Performance Sales and Earnings Analysis Ratio Analysis Stock Performance
Competitor Analysis
Major Competitors Peer Comparison at a Glance Financial Comparison Stock Chart
Company Outlook
Revenue & Income Estimates
For more information visit http://www.researchandmarkets.com/research/d67d72/johnson_johnson
SOURCE: Research and Markets Ltd.
Research and Markets Laura Wood, Senior Manager press@researchandmarkets.com U.S. Fax: 646-607-1907 Fax (outside U.S.): +353-1-481-1716
Tags: acquisition business corporate earnings executive investment investment opinion marketing merger products research revenue sales
Companies: Johnson & Johnson (JNJ)
NEW BRUNSWICK, N.J., Nov 05, 2009 /PRNewswire-FirstCall via COMTEX/ --
Johnson & Johnson (NYSE: JNJ) will participate in the Credit Suisse 18th Annual Health Care Conference on Thursday, Nov. 12, at the Arizona Biltmore Hotel. Dominic Caruso, Vice President, Finance and Chief Financial Officer, will present in a session scheduled at 10:00 a.m. (Mountain Time) or 12:00 p.m. (Eastern Time).
The webcast will be available to investors and other interested parties by accessing the Johnson & Johnson website at www.investor.jnj.com.
A webcast and podcast replay will be available approximately two hours after the live webcast.
SOURCE Johnson & Johnson
http://www.jnj.com
Tags: conference finance hotel nyse president
Companies: Johnson & Johnson (JNJ)
Total : 4,425 View more »
JOHNSON & JOHNSON; BROADSPIRE SERVICES, INC.; JOHNSON & JOHNSON LONG TERM DISABILITY INCOME PLAN FOR CHOICES ELIGIBLE EMPLOYEES OF JOHNSON & JOHNSON AND AFFILIATED COMPANIES; JOHNSON & JOHNSON PENSION COMMITTEE, Defendants, Appellees.
OMRIX is a commercial-stage company that aims to develop and market innovative biosurgical and passive immunotherapy products, utilizing its proprietary protein purification technology and manufacturing know-how.
Schuster Aguiló LLP practices in the following areas of law: Labor and Employment Law, Employment Counseling, Worker's Compensation, Civil Litigation, and Business Immigration.
http://www.lawyers.com/Puerto-Rico/San-Juan/Schuster-AguilA-LLP-1573145-f.html
Interview and discussion with Theodore Parrish of the Henssler Financial Group. He talks about Johnson and Johnson's earnings. (Bloomberg News) http://www.clipsyndicate.com/video/playlist/1998/1137692?cpt=8&wpid=523
http://www.zibb.com/article/5586916/Video+In+Depth+Look+Johnson+Johnson+Reports
Total : 90 View more »
Johnson & Johnson Incorporated company profile in Kernersville, NC. Our free company profile report for Johnson & Johnson Incorporated includes business information such as contact ...
See the company profile for JOHNSON AND JOHNS DC (JNJ) including business summary, industry/sector information, number of employees, business summary, corporate governance, key ...
Johnson & Johnson Incorporated* HQ, Branch or Single Location: Single Location: Annual Sales (Estimated) $5 to 10 million: Employees (Estimated) 50 to 99 D&B: 75*
Johnson & Johnson, incorporated in 1887, is engaged in the research and development, manufacture and sale of a range of products in the healthcare field.
http://www.reuters.com/finance/stocks/companyProfile?symbol=JNJ.N
Johnson & Johnson Consumer Products Company division of Johnson & Johnson Consumer Companies, Inc., is recruiting for a Design Manager to work out of the Los Angeles location.
http://www.coroflot.com/public/job_details.asp?job_id=21272&job_category_id_13=13
Health,... ... ...NEW BRUNSWICK N.J. Sept. 8 /- Johnson & J... ...,Johnson,&,Johnson,to,Participate,in,Morgan,Stanley,Global,Healthcare,Unplugged,Conference,medicine,medical news today,latest medical news,medical newsletters,current medical news,latest medicine news
GCI Magazine The Business Magazine for the Global Beauty Industry March 2009 Subscribe Customer Service Newsletter/RSS Business Markets & Trends Launches Events Magazine Calendar of Events Event Coverage Fragrance Business Webinars Home > Events > Event Coverage > Highlights from the 2008
http://www.gcimagazine.com/events/coverage/34671889.html?page=2
David E. Petko, PE, is currently Engineering Director, Worldwide Engineering and Real - Estate, Johnson & Johnson. He has more than 20 years of pharmaceutical manufacturing experience in the areas of solid dosage, sterile, and bioprocess engineering.
David He Vice President, Business Development, Asia Pacific Johnson & Johnson (Asia) Mr. David He joined Johnson & Johnson in October 2005 as Vice President Business Development, Asia Pacific.